Non Alcoholic Fatty Liver Disease Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GALT | B | Galectin Therapeutics Inc. | 0.82 | |
AKRO | C | Akero Therapeutics, Inc. | 0.23 | |
TERN | C | Terns Pharmaceuticals, Inc. | 4.69 | |
BLTE | C | Belite Bio, Inc. | -1.23 | |
GNFT | C | GENFIT S.A. | -0.95 | |
PLRX | C | Pliant Therapeutics, Inc. | -3.60 | |
VKTX | C | Viking Therapeutics, Inc. | -2.27 | |
ETNB | D | 89bio, Inc. | -0.94 | |
ALGS | D | Aligos Therapeutics, Inc. | 4.77 | |
GYRE | D | Gyre Therapeutics, Inc. | 5.75 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Health Information Services
Related ETFs - A few ETFs which own one or more of the above listed Non Alcoholic Fatty Liver Disease stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWM | C | iShares Russell 2000 ETF | 6.0 | |
ITOT | C | iShares Core S&P Total U.S. Stock Market ETF | 6.0 | |
IWN | C | iShares Russell 2000 Value ETF | 6.0 | |
SURI | C | Simplify Exchange Traded Funds Simplify Propel Opportunities ETF | 5.75 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 5.14 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
Health Information Services
- Non Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in the liver, causing inflammation and damage. It is the most common form of liver disease in the United States, affecting up to 25% of the population. NAFLD is closely linked to obesity, diabetes, and high cholesterol, and can lead to serious complications such as cirrhosis and liver cancer. Treatment typically involves lifestyle changes such as weight loss, exercise, and a healthy diet.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- TraderMike on EOW Scans / Signals
- CrootsterOZ on EOW Scans / Signals
- TraderMike on Filter short-term up stocks
From the Blog
Featured Articles